VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LICN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LICNLichen International Limited
$1.60$26M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

LICN logoLichen International Limited(LICN)Earnings, Financials & Key Ratios

LICN•NASDAQ
$1.60
Price updated Jul 7, 2026
SectorIndustrialsIndustryBusiness ServicesSub-IndustryProfessional Advisory and Compliance Services
AboutLichen International Ltd. engages in providing financial and taxation solutions. It also offers educational support, and software and maintenance services. The company was founded by Li Ya on April 13, 2016 and is headquartered in Jinjiang, China.Show more
  • Revenue$25M-40.9%
  • EBITDA-$10M-512.0%
  • Net Income-$22M-257.7%
  • EPS (Diluted)-4.14-909.8%
  • Gross Margin37.27%-39.8%
  • EBITDA Margin-41.83%-935.3%
  • Operating Margin-58.76%-435.5%
  • Net Margin-89.58%-505.2%
  • ROE-30.06%-235.4%

LICN Price & Volume

Lichen International Limited (LICN) stock price & volume — 10-year historical chart

Loading chart...

Structural Revenue Collapse Threatens Lichen Operational Viability

Investment Thesis • Updated 2025Q4

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Healthy
Cash Flow:Burning
Primary Risk:Structural Revenue Model Collapse

Key Thesis Takeaways

  • Lichen International Limited faces a severe structural decline as its core SME-focused service model struggles to maintain market relevance, evidenced by a 56.1% year-over-year revenue contraction in 2025Q4.
  • While the company maintains a $26.9 million cash position, the rapid erosion of retained earnings to $20.1 million and a negative 122.9% net margin suggest that current liquidity may be insufficient to support a long-term turnaround.
  • Investors should remain cautious as the firm's inability to align its fixed-cost structure with diminished demand creates significant downside risk to shareholder equity.

Verdict Logic

the company's fundamental outlook is compromised by a 56.1% revenue decline and a persistent inability to achieve operational breakeven, as demonstrated by the -89.3% operating margin in 2025Q4.

LICN Growth Metrics

Lichen International Limited (LICN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years10.22%
5 Years-4.38%
3 Years-10.15%
TTM-10.29%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-273.94%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-369.29%

Return on Capital

10 Years38.15%
5 Years11.97%
3 Years-0.82%
Last Year-19.67%

Peers Comparison

Key metrics vs top competitors for Lichen International Limited (LICN)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
LICN logoLICNLichen International LimitedCurrent
$1.60$26.12M-0.39-40.89%-89.58%-30.06%—
FEDU logoFEDUFour Seasons Education (Cayman) Inc.
$9.82$2.22M0.491.34%0.32%0.16%—
COE logoCOE51Talk Online Education Group
$16.15$1.61M-0.0989.09%-16.46%——
GOTU logoGOTUGaotu Techedu Inc.
$1.76$638.43M-14.2334.99%-5.26%-20.84%—
TAL logoTALTAL Education Group
$10.00$1.87B3.6234.21%13.82%10.85%—
EDU logoEDUNew Oriental Education & Technology Group Inc.
$47.81$7.64B20.7913.6%7.37%9.09%—

Compare LICN vs Peers

Lichen International Limited (LICN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs FEDU

Most directly comparable listed peer for LICN.

Scale Benchmark

vs BIDU

Larger-name benchmark to compare LICN against a more recognizable public peer.

Peer Set

Compare Top 5

vs FEDU, COE, GOTU, TAL

Get notified when LICN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

LICN Frequently Asked Questions

Lichen International Limited (LICN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Lichen International Limited's revenue?

Lichen International Limited (LICN) reported $66.0M in revenue for fiscal year 2025. This represents a 612% increase from $9.3M in 2014.

How fast is Lichen International Limited growing?

Lichen International Limited (LICN) saw revenue decline by 40.9% over the past year.

Is LICN profitable?

Lichen International Limited (LICN) reported a net loss of $28.1M for fiscal year 2025.

Dividend & Returns
What is LICN's return on equity?

Lichen International Limited (LICN) has a return on equity (ROE) of -30.1%. Negative ROE indicates the company is unprofitable.

What is Lichen International Limited's free cash flow?

Lichen International Limited (LICN) had negative free cash flow of $23.5M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in LICN back in 2014?

Total return calculator · dividends reinvested · 12+ years of data

See returns →